...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: For The Record
6
Sep 28, 2022 06:58AM
2
Sep 28, 2022 07:52AM

,,,and if they are,,which seemingly they are,,,,then,,,,,DMcC had nothing to do with it!!!!,,,,that's fitting,,,,he hates the retail shareholder to the extreme where he goes out of his way to misinform and limit control of our shares!!,,,its so obvious it gives me cramps!,,,pitiful,,,it can be assumed he blames us for his failures,,,,,,!! 

Share
New Message
Please login to post a reply